The authors provide an overview of the contribution of metabolomics and lipidomics in clinical studies to identify biomarkers associated with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis.
[Nature Reviews Gastroenterology & Hepatology]
7992332
{7992332:AAAAAAAA}
apa
50
1
166651
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
